P107: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE

P107: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE

Bibliographic Details
Main Authors:	J Howard, K Kuo, A Oluyadi, H Shao, S Morris, A Zaidi, E Van Beers, S Thein
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000821520.36794.7d

Similar Items

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
by: K Kuo, et al.
Published: (2022-01-01)

Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial
by: Latika Puri, et al.
Published: (2021-08-01)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
by: Myrthe van Dijk, et al.
Published: (2023-08-01)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M.J. van Dijk, et al.
Published: (2023-04-01)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: VAN DIJK M., et al.
Published: (2022-08-01)

P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
by: M. J. van Dijk, et al.
Published: (2022-06-01)

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
by: Hernández-Ojeda J, et al.
Published: (2014-09-01)

P1565: MITAPIVAT IMPROVES INEFFECTIVE ERYTHROPOIESIS AND REDUCES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
by: E. J. van Beers, et al.
Published: (2022-06-01)

P1735: IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN MITAPIVAT-TREATED PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A DESCRIPTIVE ANALYSIS FROM THE PHASE 3 ACTIVATE TRIAL
by: K. H. Kuo, et al.
Published: (2022-06-01)

Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study
by: Joerg C. Henes, et al.
Published: (2022-09-01)

P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE
by: MINNITI C., et al.
Published: (2022-08-01)

P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
by: Eduard van Beers, et al.
Published: (2023-08-01)

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
by: Marrinan, S, et al.
Published: (2017)

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
by: Jessica Mandrioli, et al.
Published: (2023-08-01)

P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL
by: Rachael F. Grace, et al.
Published: (2023-08-01)

Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
by: Michael C. Snabes, M.D., Ph.D., et al.
Published: (2023-06-01)

S273: EVIDENCE OF NONINFERIORITY OF MITAPIVAT VERSUS SPLENECTOMY IN MURINE HEREDITARY SPHEROCYTOSIS
by: A. Matte’, et al.
Published: (2022-06-01)

Tocilizumab in severe COVID-19 – A randomized, double-blind, placebo-controlled trial
by: Muhammad Irfan Malik, et al.
Published: (2022-06-01)

The effect of bromelain in periodontal surgery: a double-blind randomized placebo-controlled trial
by: Hossein Babazade, et al.
Published: (2023-05-01)

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study
by: Giacomo P. Comi, et al.
Published: (2023-01-01)

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
by: Fukuchi Y, et al.
Published: (2016-04-01)

Oral lactase for infantile colic: a randomized double-blind placebo-controlled trial
by: Manish Narang, et al.
Published: (2022-08-01)

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
by: Marcovecchio, ML, et al.
Published: (2020)

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
by: Uchio Y, et al.
Published: (2018-04-01)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
by: Wolfgang A. Schmidt, et al.
Published: (2023-10-01)

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
by: Mamta K. Jain, et al.
Published: (2022-09-01)

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
by: Kieburtz, K, et al.
Published: (2013)

Lovastatin for the treatment of adult patients with dengue: A randomized, double-blind, placebo-controlled trial.
by: Whitehorn, J, et al.
Published: (2016)

Analgesic Efficacy of Melatonin: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
by: Si Nae Oh, et al.
Published: (2020-05-01)

Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
by: Rocco Mollace, et al.
Published: (2022-01-01)

The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial.
by: Majid Ramezani, et al.
Published: (2023-01-01)

Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial
by: Hiroko Kotajima‐Murakami, et al.
Published: (2022-03-01)

Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial
by: Sanne Tofte Rasmussen, et al.
Published: (2016-10-01)

Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial
by: Ahmad Talebian, et al.
Published: (2018-02-01)

Attentional bias modification training for insomnia: A double-blind placebo controlled randomized trial.
by: Jaap Lancee, et al.
Published: (2017-01-01)

Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.
by: Langmead, L, et al.
Published: (2004)

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
by: K. P. Thompson, et al.
Published: (2022-11-01)

Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study
by: Jeffrey M. Beckett, et al.
Published: (2020-06-01)

Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients
by: Mohamed El-Tanani, et al.
Published: (2023-05-01)

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
by: Lorenzo Piemonti, et al.
Published: (2023-10-01)